Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison

Fig. 2

Longitudinal serological dynamics of SARS-CoV-2 RT-PCR positive cohort. Solid black horizontals line denote the cut-off for positivity. Blue lines represent the WHO reference panel for anti-SARS-CoV-2 immunoglobulin (NIBSC code 20/268). Each line represents one subject, the dots represent the individual samples. All assays were performed from the same sample in a head-to-head comparison. Top left: Euroimmun Anti Spike IgA; top right: Euroimmun Anti-Spike IgG; middle left: Roche Anti-Nucleocapsid; middle right: Roche Anti Spike/RBD; bottom: GenScript neutralization surrogate test

Back to article page